# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA26019 | 25 | MIC | > | 256 | ug ml-1 | ALA2379637 | ug.mL-1 | Escherichia coli | |||
2. | ALA26019 | 25 | MIC | 0 | ALA2379636 | Not Determined | Bacillus subtilis | |||||
3. | ALA26019 | 25 | MIC | 0 | ALA2379635 | Not Determined | Pseudomonas aeruginosa | |||||
4. | ALA26019 | 25 | Inhibition | = | 8.89 | % | ALA4296184 | Average; N=2 | % | Staphylococcus aureus | ||
5. | ALA26019 | 25 | Inhibition | = | 24.31 | % | ALA4296188 | Average; N=2 | % | Acinetobacter baumannii | ||
6. | ALA26019 | 25 | Inhibition | = | 4.73 | % | ALA4296187 | Average; N=2 | % | Pseudomonas aeruginosa | ||
7. | ALA26019 | 25 | Inhibition | = | 8.69 | % | ALA4296186 | Average; N=2 | % | Klebsiella pneumoniae | ||
8. | ALA26019 | 25 | Inhibition | = | -3.33 | % | ALA4296185 | Average; N=2 | % | Escherichia coli | ||
9. | ALA26019 | 25 | Inhibition | = | -1.54 | % | ALA4296190 | Average; N=2 | % | Cryptococcus neoformans | ||
10. | ALA26019 | 25 | Inhibition | = | 2.72 | % | ALA4296189 | Average; N=2 | % | Candida albicans | ||
11. | ALA26019 | 25 | inhibition | = | -0.15 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
12. | ALA26019 | 25 | Inhibition | = | 1.946 | % | ALA4495582 | % | Severe acute respiratory syndrome coronavirus 2 | |||
13. | ALA26019 | 25 | pIC50 | < | 4.7 | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | |||
14. | ALA26019 | 25 | IC50 | > | 0 | M | ALA4651403 | No. Measurements = 1 | nM | Severe acute respiratory syndrome coronavirus 2 | ||
15. | ALA26019 | 25 | inhibition | = | -0.15 | % | ALA4513082 | % | Severe acute respiratory syndrome coronavirus 2 | |||
16. | ALA26019 | 25 | inhibition | = | -4.5 | % | ALA4808150 | % | Homo sapiens | |||
17. | ALA26019 | 25 | inhibition | = | 12.8 | % | ALA4808149 | % | Homo sapiens | |||
18. | ALA26019 | 25 | Inhibition | = | 30.1 | % | ALA4303805 | % | Severe acute respiratory syndrome coronavirus 2 | |||
19. | ALA26019 | 25 | Potency | 8.913 | uM | ALA1614211 | inconclusive | nM | Homo sapiens | |||
20. | ALA26019 | 25 | Ratio | = | 0.2 | ALA3258806 | Homo sapiens |